Latest Olanzapine Stories
A new study has shown that antipsychotic drugs may be linked to weight gain in kids.
Many pediatric and adolescent patients who received second-generation antipsychotic medications experienced significant weight gain, along with varied adverse effects on cholesterol and triglyceride levels and other metabolic measures, according to a study in the October 28 issue of JAMA.
PHILADELPHIA, Sept. 2 /PRNewswire/ -- Pfizer, Inc.
OSAKA, Japan, and FORT LEE, N.J., Aug. 26 /PRNewswire/ -- Dainippon Sumitomo Pharma Co., Ltd., (DSP) announced today positive results from PEARL 2 - a phase 3 clinical trial of lurasidone for the treatment of patients with schizophrenia.
KENILWORTH, N.J., July 24 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that its investigational agent SAPHRIS(R) (asenapine) met the primary endpoint over one year of treatment in an extension study in patients with predominant, persistent negative symptoms of schizophrenia.Negative symptoms of schizophrenia include apathy, lack of emotion and poor social functioning, among others.
WALTHAM, Mass., July 23 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the patient share of Bristol-Myers Squibb/Otsuka's Abilify has grown in the first three lines of therapy since the 2008 analysis of prescribing trends in newly diagnosed schizophrenia patients.
Three interrelated, international studies examining the genetic aspects of schizophrenia and bipolar disorder have found some 30,000 gene variations that may contribute to the mental illnesses.
ADELPHI, Md., June 10 /PRNewswire-FirstCall/ -- The U.S.
The FDA announced on Friday that it is investigating the approval of three popular antipsychotic drugs for children.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.